Inoviq Ltd has released a press release.
Capital Raising
Filed with ASX ·
On 6ix: 6ix.com/news/capital-raising-59
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Israeli Patent Issued in Bard1 Core Patent Family
- Additional BARD1 Ovarian Test Results
- Grant of Japanese Patent
- Results of BARD1 ovarian cancer study
- Research and Development Update
Later from Inoviq
- Voluntary Suspension
- Contract Development Agreement Signed
- Improved Performance of BARD1 Ovarian Test
- US Patent Issued Protecting BARD1 Ovarian Test
- Quarterly Activities Report and Appendix 4C
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq